Thought leadership and expert reaction
A global team of experienced analysts is available to provide insights into the implications of the latest pharma trends and developments on:
- Marketed/pipeline drugs – Insights into licensing issues, product development, and the clinical/commercial potential of disease treatments.
- Leading/emerging companies – Assessments of company performances and prospects, including growth forecasts and competitive positioning.
- Disease areas – Analysis of treatment trends, marketed/pipeline products, and hot topics for all major diseases and conditions.
- Patient insights – Epidemiological research, with analysis of unmet needs and disease incidence/prevalence forecasts across key countries.
- Industry trends – Expertise on evolving strategic issues, including outsourcing, reimbursement, and lifecycle management.
Contact our team for expert reaction on breaking industry news, including drug approvals/withdrawals, clinical trial results, M&A activity, company sales announcements, and regulatory developments.
For enquiries related to press releases, analyst comment, or to arrange an interview, please contact our dedicated PR team using the details below, or submit your details through the adjacent form.